Japan Tissue Engineering Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3389610001
JPY
581.00
-7 (-1.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
H.U. Group Holdings, Inc.
BML, Inc.
PLATZ Co., Ltd.
TOWA Hi SYSTEM Co., Ltd.
I'rom Group Co., Ltd.
Uchiyama Holdings Co., Ltd.
Signpost Corp. (Tokyo)
Amvis Holdings, Inc.
Japan Tissue Engineering Co., Ltd.
CMIC Holdings Co., Ltd.
DNA Chip Research, Inc.

Why is Japan Tissue Engineering Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 0.47%
  • The company has been able to generate a Return on Equity (avg) of 0.47% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 0.64% and Operating profit at -19.88% over the last 5 years
3
The company has declared negative results for the last 3 consecutive quarters
  • PRE-TAX PROFIT(Q) At JPY -183.82 MM has Fallen at -85.11%
  • NET PROFIT(Q) At JPY -184.85 MM has Fallen at -84.23%
  • ROCE(HY) Lowest at -8.39%
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 2.80%, its profits have fallen by -201%
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 2.80% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 69.64%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Japan Tissue Engineering Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Japan Tissue Engineering Co., Ltd.
-2.84%
-0.33
57.88%
Japan Nikkei 225
71.75%
2.62
26.55%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.64%
EBIT Growth (5y)
-19.88%
EBIT to Interest (avg)
-357.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.41
Tax Ratio
8.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.59%
ROE (avg)
0.47%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.03
EV to EBIT
-49.25
EV to EBITDA
-74.17
EV to Capital Employed
11.97
EV to Sales
10.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-24.30%
ROE (Latest)
-8.76%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
NO KEY POSITIVE TRIGGERS
-26What is not working for the Company
PRE-TAX PROFIT(Q)

At JPY -183.82 MM has Fallen at -85.11%

NET PROFIT(Q)

At JPY -184.85 MM has Fallen at -84.23%

ROCE(HY)

Lowest at -8.39%

NET SALES(Q)

At JPY 510.92 MM has Fallen at -10.85%

RAW MATERIAL COST(Y)

Grown by 5.11% (YoY

CASH AND EQV(HY)

Lowest at JPY 7,064.28 MM

DEBT-EQUITY RATIO (HY)

Highest at -63.31 %

Here's what is not working for Japan Tissue Engineering Co., Ltd.

Pre-Tax Profit
At JPY -183.82 MM has Fallen at -85.11%
over average net sales of the previous four periods of JPY -99.3 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY -184.85 MM has Fallen at -84.23%
over average net sales of the previous four periods of JPY -100.34 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Net Sales
At JPY 510.92 MM has Fallen at -10.85%
over average net sales of the previous four periods of JPY 573.07 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (JPY MM)

Cash and Eqv
Lowest at JPY 7,064.28 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -63.31 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 5.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales